Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Co-Diagnostics Inc (CODX)

Co-Diagnostics Inc (CODX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,562
  • Shares Outstanding, K 2,095
  • Annual Sales, $ 3,920 K
  • Annual Income, $ -37,640 K
  • EBIT $ -34 M
  • EBITDA $ -33 M
  • 60-Month Beta 1.31
  • Price/Sales 4.11
  • Price/Cash Flow N/A
  • Price/Book 0.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate $-3.90
  • Number of Estimates 1
  • High Estimate $-3.90
  • Low Estimate $-3.90
  • Prior Year $-10.81
  • Growth Rate Est. (year over year) +63.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6600 +12.05%
on 03/27/26
4.4000 -57.73%
on 03/10/26
-0.4400 (-19.13%)
since 02/27/26
3-Month
1.6600 +12.05%
on 03/27/26
7.1910 -74.13%
on 12/29/25
-5.1900 (-73.62%)
since 12/26/25
52-Week
1.6600 +12.05%
on 03/27/26
46.5000 -96.00%
on 10/27/25
-7.7400 (-80.63%)
since 03/28/25

Most Recent Stories

More News
Co-Diagnostics Reports Full Year 2025 Financial Results

Advancing Global Commercialization Strategy Through CoSara and CoMira Joint Ventures

CODX : 1.8600 (+9.41%)
Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

The near-term commencement of clinical studies is expected to align with recent WHO tuberculosis recommendations for near-point-of-care molecular testing and utilizing tongue swab samples

CODX : 1.8600 (+9.41%)
Co-Diagnostics (NASDAQ: CODX) Expands CoSara Distribution Territory Across South Asia

Co-Diagnostics (NASDAQ: CODX) announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd., has signed an agreement to expand its commercial and distribution territory across South Asia to...

CODX : 1.8600 (+9.41%)
Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

Expansion into Bangladesh, Pakistan, Nepal, and Sri Lanka increases TAM in region to $13 billion and supports commercialization strategy for the PCR Pro ® and SARAGENE ® product...

CODX : 1.8600 (+9.41%)
Co-Diagnostics to Present at Medical Korea 2026

Co-Dx to join WTC Utah and other Utah legislative and industry delegates March 19-22 in Seoul, South Korea

CODX : 1.8600 (+9.41%)
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

SALT LAKE CITY , March 12, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...

CODX : 1.8600 (+9.41%)
Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

SALT LAKE CITY , March 10, 2026 /PRNewswire/ --  Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...

CODX : 1.8600 (+9.41%)
Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

SALT LAKE CITY , Feb. 9, 2026 /PRNewswire/ -- Co-Diagnostics, Inc .  (OTC: CODX)  ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...

CODX : 1.8600 (+9.41%)
Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or distribution

CODX : 1.8600 (+9.41%)
Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Company and CoSara believe that ISO certification is a critical component of the regulatory requirements for clearance of new platform

CODX : 1.8600 (+9.41%)

Business Summary

Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology...

See More

Key Turning Points

3rd Resistance Point 2.1425
2nd Resistance Point 2.0300
1st Resistance Point 1.9450
Last Price 1.8600
1st Support Level 1.7475
2nd Support Level 1.6350
3rd Support Level 1.5500

See More

52-Week High 46.5000
Fibonacci 61.8% 29.3711
Fibonacci 50% 24.0800
Fibonacci 38.2% 18.7889
Last Price 1.8600
52-Week Low 1.6600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.